Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review
Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Most conventional insomnia medications are gamma‐aminobutylic acid receptor agonists. However, physical dependence is a concern and one of the major limiting factors for long‐term treatment. The dual orexin receptor antagonists, suvorexant and lemborexant, were recently approved for treating chronic insomnia, giving a novel pharmacotherapeutic opti...
Alternative Titles
Full title
Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e1c3cd06cd9f45a8a585f4644d879cd0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e1c3cd06cd9f45a8a585f4644d879cd0
Other Identifiers
ISSN
2574-173X
E-ISSN
2574-173X
DOI
10.1002/npr2.12205
